Wolfgang Söhngen
Director/Board Member en Metys Pharmaceuticals AG .
Perfil
Wolfgang Söhngen was the founder of PAION AG, which was founded in 2000, where he held the title of Chief Executive Officer from 2000 to 2019.
He is currently a Director at Metys Pharmaceuticals AG.
Dr. Söhngen's former positions include Co-Managing Director at Paion Deutschland GmbH, Non-Executive Director at PAION, Inc., and Head-Corporate Development & Strategic planning at Grünenthal GmbH from 1987 to 1997.
Dr. Söhngen received his undergraduate and doctorate degrees from RWTH Aachen University in 1985.
Cargos activos de Wolfgang Söhngen
| Empresas | Cargo | Inicio |
|---|---|---|
Metys Pharmaceuticals AG
 Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The private company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Director/Board Member | - |
Antiguos cargos conocidos de Wolfgang Söhngen.
| Empresas | Cargo | Fin |
|---|---|---|
PAION, Inc.
 PAION, Inc. Pharmaceuticals: MajorHealth Technology Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The private company is based in Mahwah, NJ. | Director/Board Member | 01/11/2019 |
| PAION AG | Chief Executive Officer | 16/10/2019 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Corporate Officer/Principal | 01/12/1997 |
Paion Deutschland GmbH
 Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Chief Executive Officer | - |
Formación de Wolfgang Söhngen.
| RWTH Aachen University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PAION AG | Health Technology |
| Empresas privadas | 4 |
|---|---|
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Health Technology |
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The private company is based in Mahwah, NJ. | Health Technology |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The private company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Wolfgang Söhngen
